The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

(Reuters) - Botox maker AbbVie Inc's Allergan unit has accused Revance Therapeutics Inc in a federal lawsuit of poaching key employees in a "desperate" effort to compete in the market for anti-wrinkle ...

Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...

IRVINE, Calif., Sept. 11, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie (ABBV) company, today announced that BOTOX ® Cosmetic (onabotulinumtoxinA) is now available for the treatment of masseter ...

Allergan plc AGN announced that the FDA has approved its Botox Cosmetic product for a third indication — temporary improvement of moderate to severe forehead lines in appearance, associated with ...

Pyott: “This has been the best year for R&D approvals ever” Irvine drug maker Allergan Inc. has built itself into a multibillion dollar company by going after, and even creating, new markets. Now it’s ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

"At my practice, we leverage Allē to ensure BOTOX ® Cosmetic Day is successful for patients looking to explore the results that can be achieved with BOTOX ® Cosmetic," said Dr. David Shafer, double ...

Botox is everywhere right now. It’s nearly impossible to walk down a city block or through a suburban strip mall without seeing signs in med spas or even hair salon windows advertising it—sometimes at ...

BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety ...